SEC CIK 1212449
BALSON ANDREW
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| BLMNview stock → | 52,263,046 | 2013-05-29 |
| DPZview stock → | 2,988 | 2026-09-30 |
Position History — DPZ
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — DPZ
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-09-30 | Grant / award | 101 | $0.00 | 2,988 |
| 2026-06-30 | Grant / award | 102 | $0.00 | 2,887 |
| 2026-04-21 | Grant / award | 515 | $0.00 | 2,785 |
| 2026-03-10 | Grant / award | 75 | $0.00 | 2,270 |
| 2025-04-23 | Grant / award | 392 | $0.00 | 7,518 |
| 2025-03-03 | Open-market sale | 1,000 | $491.29 | 11,451 |
| 2025-03-03 | Open-market sale | 1,850 | $493.81 | 7,226 |
| 2025-03-03 | Open-market sale | 100 | $494.18 | 7,126 |
| 2025-03-03 | Open-market sale | 2,375 | $492.60 | 9,076 |
| 2025-03-03 | Open-market sale | 375 | $489.33 | 12,751 |
| 2025-03-03 | Open-market sale | 300 | $490.24 | 12,451 |
| 2024-12-10 | Grant / award | 61 | $0.00 | 13,126 |
| 2024-10-15 | Open-market sale | 3,970 | $427.39 | 18,390 |
| 2024-10-15 | Gift | 2,325 | $0.00 | 13,065 |
| 2024-10-15 | Open-market sale | 3,000 | $429.43 | 15,390 |
| 2024-09-30 | Grant / award | 64 | $0.00 | 22,360 |
| 2024-07-01 | Grant / award | 55 | $0.00 | 22,296 |
| 2024-04-25 | Grant / award | 385 | $0.00 | 22,241 |
| 2024-03-11 | Grant / award | 62 | $0.00 | 21,856 |
| 2023-12-13 | Grant / award | 66 | $0.00 | 21,794 |
| 2023-10-02 | Grant / award | 69 | $0.00 | 21,728 |
| 2023-08-09 | Gift | 7,575 | $0.00 | 21,659 |
| 2023-08-08 | Open-market sale | 200 | $398.74 | 29,234 |
| 2023-08-08 | Open-market sale | 983 | $398.12 | 29,434 |
| 2023-08-08 | Open-market sale | 1,432 | $396.06 | 32,865 |
| 2023-08-08 | Open-market sale | 2,448 | $397.00 | 30,417 |
| 2023-06-30 | Grant / award | 78 | $0.00 | 34,297 |
| 2023-04-25 | Grant / award | 531 | $0.00 | 34,219 |
| 2023-03-10 | Grant / award | 92 | $0.00 | 33,688 |
| 2022-07-26 | Open-market sale | 10,000 | $385.00 | 33,596 |
| 2022-07-25 | Open-market sale | 1,800 | $387.20 | 25,510 |
| 2022-07-25 | Open-market sale | 200 | $387.71 | 25,310 |
| 2022-07-25 | Open-market sale | 2,000 | $387.24 | 6,870 |
| 2022-04-26 | Grant / award | 474 | $0.00 | 43,596 |
| 2021-04-27 | Grant / award | 399 | $0.00 | 43,122 |
| 2020-04-21 | Grant / award | 440 | $0.00 | 57,723 |
| 2020-01-24 | Option exercise (derivative) | 6,000 | $0.00 | 0 |
| 2020-01-24 | Option exercise | 6,000 | $12.43 | 57,283 |
| 2019-02-20 | Grant / award | 450 | $0.00 | 51,283 |
| 2019-02-01 | Option exercise (derivative) | 20,000 | $0.00 | 0 |
| 2019-02-01 | Option exercise | 20,000 | $6.59 | 50,833 |
| 2018-02-14 | Grant / award | 590 | $0.00 | 30,833 |
| 2018-01-19 | Option exercise (derivative) | 9,000 | $10.06 | 0 |
| 2018-01-19 | Option exercise | 9,000 | $10.06 | 30,243 |
| 2017-02-15 | Grant / award | 600 | $0.00 | 21,243 |
| 2016-02-24 | Grant / award | 940 | $0.00 | 20,643 |
| 2015-07-22 | Open-market buy | 13,310 | $112.33 | 27,310 |
| 2015-07-22 | Open-market buy | 8,870 | $112.33 | 8,870 |
| 2015-02-11 | Grant / award | 1,000 | $0.00 | 19,703 |
| 2014-05-22 | J | 14,000 | $0.00 | 18,703 |
| 2014-02-12 | Grant / award | 1,420 | $0.00 | 32,703 |
| 2013-02-27 | Grant / award | 2,600 | $0.00 | 31,283 |
| 2013-02-13 | Grant / award | 2,200 | $0.00 | 28,683 |
| 2012-02-23 | Grant / award | 2,990 | $0.00 | 26,483 |
| 2011-02-23 | Grant / award | 6,250 | $0.00 | 23,493 |
| 2010-12-08 | Open-market sale | 148,000 | $15.59 | 0 |
| 2010-12-08 | Open-market sale | 148,000 | $15.59 | 0 |
| 2010-12-02 | Open-market sale | 3,964 | $14.94 | 148,000 |
| 2010-12-02 | Open-market sale | 3,964 | $14.94 | 148,000 |
| 2010-11-22 | Open-market sale | 18,572 | $14.64 | 151,964 |
| 2010-11-22 | Open-market sale | 18,572 | $14.64 | 151,964 |
| 2010-11-09 | J | 2,556,594 | $15.55 | 172,203 |
| 2010-11-09 | J | 2,638 | $0.00 | 17,243 |
| 2010-11-09 | J | 2,638 | $0.00 | 17,243 |
| 2010-11-09 | J | 2,556,594 | $15.55 | 172,203 |
| 2010-11-02 | Open-market sale | 3,977 | $15.09 | 2,728,797 |
| 2010-11-02 | Open-market sale | 18,633 | $15.00 | 2,732,774 |
| 2010-11-02 | Open-market sale | 3,977 | $15.09 | 2,728,797 |
| 2010-11-02 | Open-market sale | 18,633 | $15.00 | 2,732,774 |
| 2010-10-26 | J | 2,715,280 | $15.36 | 2,751,407 |
| 2010-10-26 | J | 3,199 | $0.00 | 14,605 |
| 2010-10-25 | Open-market sale | 3,977 | $15.35 | 5,466,687 |
| 2010-10-22 | Open-market sale | 18,633 | $15.24 | 5,470,664 |
| 2010-10-21 | J | 2,715,280 | $15.59 | 5,489,297 |
| 2010-10-21 | J | 3,199 | $0.00 | 11,406 |
| 2010-03-19 | Open-market sale | 3,314 | $13.37 | 8,204,577 |
| 2010-03-18 | J | 1,336 | $0.00 | 8,207 |
| 2010-03-18 | Open-market sale | 15,528 | $13.52 | 8,207,891 |
| 2010-03-18 | J | 2,262,732 | $14.19 | 8,223,419 |
| 2010-03-16 | Open-market sale | 3,314 | $14.00 | 10,486,151 |
| 2010-03-11 | Open-market sale | 15,528 | $13.84 | 10,489,465 |
| 2010-03-10 | J | 1,336 | $0.00 | 9,271 |
| 2010-03-10 | J | 2,262,732 | $14.19 | 10,504,993 |
| 2010-03-10 | Gift | 2,400 | $0.00 | 6,871 |
| 2010-03-05 | Open-market sale | 3,977 | $13.82 | 12,767,725 |
| 2010-03-04 | Open-market sale | 18,634 | $13.60 | 12,771,702 |
| 2010-03-04 | J | 1,604 | $0.00 | 7,604 |
| 2010-03-04 | J | 2,715,278 | $13.60 | 12,790,336 |
| 2010-02-25 | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2010-02-25 | Grant / award | 6,000 | $0.00 | 6,000 |
| 2009-06-01 | Grant / award (derivative) | 9,000 | $0.00 | 9,000 |
| 2009-06-01 | Disposition to issuer (derivative) | 10,000 | — | 0 |
| 2009-02-10 | Grant / award (derivative) | 20,000 | $6.59 | 20,000 |
| 2008-02-13 | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2006-03-10 | Open-market sale | 4,848,731 | $25.78 | 16,089,968 |
| 2006-03-10 | J | 477,224 | — | 20,938,699 |
| 2005-12-09 | Open-market sale | 7,400 | $24.79 | 21,415,923 |
| 2005-11-30 | Open-market sale | 52,000 | $25.08 | 22,106,986 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.